Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Phreesia, Inc. (PHR)
since 2019 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Phreesia, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1412408.
Total stock buying since 2019: $0.
Total stock sales since 2019: $395,710,356.
Total stock option exercises since 2019: $5,597,798.
Table 3. Detailed insider trading at Phreesia, Inc. (PHR)
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2025-08-28 | Indig Chaim (Chief Executive Officer) | Sale | 7,746 | 32.47 | 251,473 |
2025-08-28 | Indig Chaim (Chief Executive Officer) | Option Ex | 7,746 | 6.37 | 49,342 |
2025-08-28 | Roberts Evan (President, Provider Solutions) | Sale | 3,400 | 32.46 | 110,370 |
2025-08-27 | Indig Chaim (Chief Executive Officer) | Sale | 92,247 | 32.02 | 2,953,472 |
2025-08-27 | Indig Chaim (Chief Executive Officer) | Option Ex | 92,247 | 6.37 | 587,613 |
2025-08-27 | Roberts Evan (President, Provider Solutions) | Sale | 45,147 | 32.02 | 1,445,606 |
2025-08-25 | Gandhi Balaji (Chief Financial Officer) | Sale | 9,583 | 30.01 | 287,547 |
2025-08-25 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 18,573 | 30.37 | 564,062 |
2025-08-25 | Weintraub Michael (Director) | Sale | 10,000 | 30.00 | 300,000 |
2025-08-25 | Weintraub Michael (Director) | Option Ex | 10,000 | 6.37 | 63,700 |
2025-08-22 | Linetsky David (President, Network Solutions) | Sale | 17,445 | 29.73 | 518,674 |
2025-08-18 | Linetsky David (President, Network Solutions) | Sale | 78 | 29.16 | 2,274 |
2025-07-18 | Hui Yvonne (Principal Accounting Officer) | Sale | 626 | 26.23 | 16,419 |
2025-07-17 | Hui Yvonne (Principal Accounting Officer) | Sale | 465 | 26.89 | 12,501 |
2025-07-17 | Gandhi Balaji (Chief Financial Officer) | Sale | 886 | 26.89 | 23,820 |
2025-07-17 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 640 | 26.89 | 17,207 |
2025-07-17 | Indig Chaim (Chief Executive Officer) | Sale | 3,171 | 26.89 | 85,255 |
2025-07-17 | Linetsky David (SVP, Network Solutions) | Sale | 2,063 | 26.89 | 55,465 |
2025-07-17 | Roberts Evan (Chief Operating Officer) | Sale | 1,892 | 26.89 | 50,868 |
2025-07-17 | Hoffman Allison C (General Counsel & Secretary) | Sale | 1,245 | 26.89 | 33,473 |
2025-07-16 | Hui Yvonne (Principal Accounting Officer) | Sale | 1,266 | 26.95 | 34,116 |
2025-07-15 | Hui Yvonne (Principal Accounting Officer) | Sale | 921 | 27.27 | 25,113 |
2025-07-15 | Egbuonu-davis Lisa (Director) | Sale | 1,395 | 27.64 | 38,556 |
2025-07-07 | Hui Yvonne (Principal Accounting Officer) | Sale | 571 | 28.85 | 16,473 |
2025-07-02 | Smith Mark Douglas (Director) | Sale | 7,000 | 29.00 | 203,000 |
2025-07-02 | Smith Mark Douglas (Director) | Option Ex | 7,000 | 4.71 | 32,970 |
2025-06-27 | Linetsky David (SVP, Network Solutions) | Sale | 23,729 | 28.50 | 676,205 |
2025-06-18 | Linetsky David (SVP, Network Solutions) | Sale | 67 | 25.61 | 1,715 |
2025-06-17 | Linetsky David (SVP, Network Solutions) | Sale | 42 | 25.17 | 1,057 |
2025-06-10 | Hui Yvonne (Principal Accounting Officer) | Sale | 582 | 28.00 | 16,296 |
2025-06-10 | Weintraub Michael (Director) | Sale | 2,569 | 27.86 | 71,567 |
2025-06-10 | Weintraub Michael (Director) | Option Ex | 2,569 | 4.71 | 12,099 |
2025-06-09 | Weintraub Michael (Director) | Sale | 7,431 | 27.51 | 204,441 |
2025-06-09 | Weintraub Michael (Director) | Option Ex | 7,431 | 4.71 | 35,000 |
2025-04-22 | Hui Yvonne (Principal Accounting Officer) | Sale | 1,330 | 23.70 | 31,521 |
2025-04-21 | Hui Yvonne (Principal Accounting Officer) | Sale | 993 | 23.04 | 22,880 |
2025-04-21 | Linetsky David (SVP, Life Sciences) | Sale | 260 | 23.04 | 5,990 |
2025-04-16 | Hui Yvonne (Principal Accounting Officer) | Sale | 418 | 23.66 | 9,889 |
2025-04-16 | Gandhi Balaji (Chief Financial Officer) | Sale | 864 | 23.81 | 20,569 |
2025-04-16 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 624 | 23.81 | 14,855 |
2025-04-16 | Indig Chaim (Chief Executive Officer) | Sale | 3,091 | 23.81 | 73,587 |
2025-04-16 | Linetsky David (SVP, Life Sciences) | Sale | 4,499 | 23.73 | 106,779 |
2025-04-16 | Roberts Evan (Chief Operating Officer) | Sale | 1,845 | 23.81 | 43,923 |
2025-04-16 | Hoffman Allison C (General Counsel & Secretary) | Sale | 1,213 | 23.81 | 28,877 |
2025-04-15 | Hui Yvonne (Principal Accounting Officer) | Sale | 314 | 24.04 | 7,549 |
2025-04-09 | Hui Yvonne (Principal Accounting Officer) | Sale | 2,802 | 23.23 | 65,090 |
2025-04-09 | Hoffman Allison C (General Counsel & Secretary) | Sale | 4,696 | 23.23 | 109,088 |
2025-04-08 | Hui Yvonne (Principal Accounting Officer) | Sale | 1,878 | 23.97 | 45,008 |
2025-04-08 | Gandhi Balaji (Chief Financial Officer) | Sale | 8,045 | 23.97 | 192,806 |
2025-04-08 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 1,695 | 23.97 | 40,622 |
2025-04-08 | Indig Chaim (Chief Executive Officer) | Sale | 12,167 | 23.97 | 291,594 |
2025-04-08 | Linetsky David (SVP, Life Sciences) | Sale | 4,192 | 23.97 | 100,465 |
2025-04-08 | Roberts Evan (Chief Operating Officer) | Sale | 7,233 | 23.97 | 173,346 |
2025-04-08 | Hoffman Allison C (General Counsel & Secretary) | Sale | 6,024 | 23.97 | 144,371 |
2025-03-26 | Gandhi Balaji (Chief Financial Officer) | Sale | 1,827 | 27.46 | 50,176 |
2025-03-19 | Linetsky David (SVP, Life Sciences) | Sale | 88 | 28.08 | 2,471 |
2025-03-18 | Linetsky David (SVP, Life Sciences) | Sale | 39 | 26.95 | 1,051 |
2025-03-17 | Hoffman Allison C (General Counsel & Secretary) | Sale | 3,496 | 25.32 | 88,518 |
2025-02-07 | Linetsky David (SVP, Life Sciences) | Sale | 300 | 29.52 | 8,856 |
2025-02-05 | Linetsky David (SVP, Life Sciences) | Sale | 720 | 29.50 | 21,240 |
2025-01-29 | Linetsky David (SVP, Life Sciences) | Sale | 500 | 29.68 | 14,841 |
2025-01-28 | Hoffman Allison C (General Counsel & Secretary) | Sale | 6,235 | 28.50 | 177,697 |
2025-01-27 | Gandhi Balaji (Chief Financial Officer) | Sale | 4,813 | 27.67 | 133,166 |
2025-01-27 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 3,475 | 27.67 | 96,146 |
2025-01-27 | Indig Chaim (Chief Executive Officer) | Sale | 26,248 | 27.67 | 726,229 |
2025-01-27 | Linetsky David (SVP, Life Sciences) | Sale | 11,685 | 27.67 | 323,300 |
2025-01-27 | Roberts Evan (Chief Operating Officer) | Sale | 10,716 | 27.67 | 296,490 |
2025-01-27 | Hoffman Allison C (General Counsel & Secretary) | Sale | 6,556 | 27.67 | 181,391 |
2025-01-24 | Hui Yvonne (Principal Accounting Officer) | Sale | 127 | 28.00 | 3,556 |
2025-01-21 | Gandhi Balaji (Chief Financial Officer) | Sale | 5,827 | 27.31 | 159,141 |
2025-01-21 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 4,720 | 27.31 | 128,907 |
2025-01-21 | Indig Chaim (Chief Executive Officer) | Sale | 21,692 | 27.31 | 592,430 |
2025-01-21 | Linetsky David (SVP, Life Sciences) | Sale | 13,873 | 27.31 | 378,885 |
2025-01-21 | Roberts Evan (Chief Operating Officer) | Sale | 12,749 | 27.31 | 348,187 |
2025-01-21 | Hoffman Allison C (General Counsel & Secretary) | Sale | 8,426 | 27.31 | 230,122 |
2025-01-15 | Hui Yvonne (Principal Accounting Officer) | Sale | 381 | 26.87 | 10,237 |
2025-01-15 | Gandhi Balaji (Chief Financial Officer) | Sale | 836 | 26.98 | 22,556 |
2025-01-15 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 604 | 26.98 | 16,296 |
2025-01-15 | Indig Chaim (Chief Executive Officer) | Sale | 2,990 | 26.98 | 80,673 |
2025-01-15 | Linetsky David (SVP, Life Sciences) | Sale | 1,946 | 26.98 | 52,505 |
2025-01-15 | Roberts Evan (Chief Operating Officer) | Sale | 1,785 | 26.98 | 48,161 |
2025-01-15 | Hoffman Allison C (General Counsel & Secretary) | Sale | 4,585 | 26.93 | 123,455 |
2025-01-14 | Hui Yvonne (Principal Accounting Officer) | Sale | 362 | 26.38 | 9,548 |
2025-01-10 | Hui Yvonne (Principal Accounting Officer) | Sale | 388 | 27.85 | 10,805 |
2025-01-08 | Hui Yvonne (Principal Accounting Officer) | Sale | 288 | 28.00 | 8,064 |
2025-01-08 | Roberts Evan (Chief Operating Officer) | Sale | 2,681 | 28.07 | 75,255 |
2025-01-07 | Roberts Evan (Chief Operating Officer) | Sale | 7,319 | 27.00 | 197,613 |
2025-01-06 | Gandhi Balaji (Chief Financial Officer) | Sale | 3,195 | 26.61 | 85,006 |
2025-01-06 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 1,311 | 26.61 | 34,880 |
2025-01-06 | Indig Chaim (Chief Executive Officer) | Sale | 5,375 | 26.61 | 143,007 |
2025-01-06 | Linetsky David (SVP, Life Sciences) | Sale | 3,133 | 26.61 | 83,356 |
2025-01-06 | Roberts Evan (Chief Operating Officer) | Sale | 2,873 | 26.61 | 76,439 |
2025-01-06 | Hoffman Allison C (General Counsel & Secretary) | Sale | 3,982 | 26.61 | 105,945 |
2024-12-18 | Linetsky David (SVP, Life Sciences) | Sale | 24 | 25.38 | 609 |
2024-12-18 | Hoffman Allison C (General Counsel & Secretary) | Sale | 3,495 | 24.88 | 86,955 |
2024-12-17 | Linetsky David (SVP, Life Sciences) | Sale | 61 | 25.40 | 1,549 |
2024-12-16 | Weintraub Michael (Director) | Sale | 861 | 25.26 | 21,752 |
2024-12-16 | Weintraub Michael (Director) | Option Ex | 861 | 4.71 | 4,055 |
2024-12-16 | Linetsky David (SVP, Life Sciences) | Sale | 35 | 24.88 | 870 |
2024-12-13 | Weintraub Michael (Director) | Sale | 20,565 | 25.04 | 515,029 |
2024-12-13 | Weintraub Michael (Director) | Option Ex | 20,565 | 4.71 | 96,861 |
2024-12-11 | Weintraub Michael (Director) | Sale | 18,574 | 25.10 | 466,188 |
2024-12-11 | Weintraub Michael (Director) | Option Ex | 18,574 | 4.71 | 87,483 |
2024-12-11 | Linetsky David (SVP, Life Sciences) | Sale | 11,853 | 24.85 | 294,558 |
2024-12-10 | Roberts Evan (Chief Operating Officer) | Sale | 25,000 | 24.09 | 602,150 |
2024-12-03 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 25,447 | 20.93 | 532,554 |
2024-12-02 | Weintraub Michael (Director) | Sale | 15,152 | 21.01 | 318,373 |
2024-12-02 | Weintraub Michael (Director) | Option Ex | 15,152 | 2.03 | 30,758 |
2024-10-18 | Linetsky David (SVP, Life Sciences) | Sale | 1,100 | 20.49 | 22,539 |
2024-10-16 | Hui Yvonne (Principal Accounting Officer) | Sale | 423 | 21.33 | 9,022 |
2024-10-15 | Hui Yvonne (Principal Accounting Officer) | Sale | 2,791 | 20.97 | 58,521 |
2024-10-15 | Gandhi Balaji (Chief Financial Officer) | Sale | 864 | 21.02 | 18,165 |
2024-10-15 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 624 | 21.02 | 13,119 |
2024-10-15 | Indig Chaim (Chief Executive Officer) | Sale | 3,089 | 21.02 | 64,946 |
2024-10-15 | Linetsky David (SVP, Life Sciences) | Sale | 2,011 | 21.02 | 42,281 |
2024-10-15 | Roberts Evan (Chief Operating Officer) | Sale | 1,843 | 21.02 | 38,749 |
2024-10-15 | Hoffman Allison C (General Counsel & Secretary) | Sale | 1,212 | 21.02 | 25,482 |
2024-09-19 | Linetsky David (SVP, Life Sciences) | Sale | 24 | 24.04 | 577 |
2024-09-18 | Linetsky David (SVP, Life Sciences) | Sale | 61 | 24.09 | 1,469 |
2024-09-17 | Linetsky David (SVP, Life Sciences) | Sale | 36 | 24.77 | 891 |
2024-09-12 | Egbuonu-davis Lisa (Director) | Sale | 1,400 | 23.03 | 32,239 |
2024-09-11 | Hoffman Allison C (General Counsel & Secretary) | Sale | 2,072 | 23.36 | 48,401 |
2024-09-10 | Hui Yvonne (Principal Accounting Officer) | Sale | 744 | 23.25 | 17,298 |
2024-09-10 | Gandhi Balaji (Chief Financial Officer) | Sale | 3,502 | 23.25 | 81,421 |
2024-09-10 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 737 | 23.25 | 17,135 |
2024-09-10 | Indig Chaim (Chief Executive Officer) | Sale | 5,295 | 23.25 | 123,108 |
2024-09-10 | Linetsky David (SVP, Life Sciences) | Sale | 1,811 | 23.25 | 42,105 |
2024-09-10 | Roberts Evan (Chief Operating Officer) | Sale | 3,148 | 23.25 | 73,191 |
2024-09-10 | Hoffman Allison C (General Counsel & Secretary) | Sale | 2,622 | 23.25 | 60,961 |
2024-08-26 | Hoffman Allison C (General Counsel & Secretary) | Sale | 14,110 | 26.03 | 367,240 |
2024-07-29 | Indig Chaim (Chief Executive Officer) | Sale | 7 | 24.75 | 173 |
2024-07-29 | Indig Chaim (Chief Executive Officer) | Option Ex | 7 | 2.03 | 14 |
2024-07-18 | Smith Mark Douglas (Director) | Sale | 7,000 | 25.00 | 175,000 |
2024-07-18 | Smith Mark Douglas (Director) | Option Ex | 7,000 | 4.71 | 32,970 |
2024-07-16 | Hui Yvonne (Principal Accounting Officer) | Sale | 283 | 23.74 | 6,717 |
2024-07-16 | Gandhi Balaji (Chief Financial Officer) | Sale | 783 | 23.74 | 18,585 |
2024-07-16 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 374 | 23.74 | 8,877 |
2024-07-16 | Indig Chaim (Chief Executive Officer) | Sale | 2,644 | 23.74 | 62,757 |
2024-07-16 | Linetsky David (SVP, Life Sciences) | Sale | 1,820 | 23.74 | 43,199 |
2024-07-16 | Roberts Evan (Chief Operating Officer) | Sale | 1,669 | 23.74 | 39,615 |
2024-07-16 | Hoffman Allison C (General Counsel & Secretary) | Sale | 800 | 23.74 | 18,988 |
2024-06-21 | Linetsky David (SVP, Life Sciences) | Sale | 27 | 20.24 | 546 |
2024-06-21 | Gunzburg Janet (Principal Accounting Officer) | Sale | 114 | 20.24 | 2,307 |
2024-06-20 | Linetsky David (SVP, Life Sciences) | Sale | 66 | 19.73 | 1,302 |
2024-06-18 | Linetsky David (SVP, Life Sciences) | Sale | 41 | 19.20 | 787 |
2024-05-01 | Gunzburg Janet (Principal Accounting Officer) | Sale | 286 | 21.00 | 6,005 |
2024-04-18 | Linetsky David (SVP, Life Sciences) | Sale | 269 | 22.85 | 6,145 |
2024-04-18 | Gunzburg Janet (Principal Accounting Officer) | Sale | 912 | 22.85 | 20,836 |
2024-04-15 | Gandhi Balaji (Chief Financial Officer) | Sale | 948 | 22.86 | 21,668 |
2024-04-15 | Vanduyn Amy Beth (SVP, Human Resources) | Sale | 685 | 22.86 | 15,657 |
Insider trading activities including stock purchases, stock sales, and option exercises
of PHR listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Phreesia, Inc. (symbol PHR,
CIK number 1412408) see
the Securities and Exchange Commission (SEC) website.